Consortional main: Cytogenetic and immunology markers predicting the outcome and late sequel of radiation therapy  Page description

Help  Print 
Back »

 

Details of project

 
Identifier
124879
Type K
Principal investigator Sáfrány, Géza
Title in Hungarian Konzorcium, fő p.: Prosztata tumoros betegek túlélésének és a sugárterápia következtében kialakuló késői mellékhatások kockázatának a becslésére alkalmas citogenetikai és immunológiai markereknek az azonosítása
Title in English Consortional main: Cytogenetic and immunology markers predicting the outcome and late sequel of radiation therapy
Keywords in Hungarian prosztata tumor, sugárterápia, biomarker, immunmarker
Keywords in English prostate tumor, radiotherapy, biomarker, immunology marker
Discipline
Cancer and its biological basis (Council of Medical and Biological Sciences)85 %
Radiology, nuclear medicine and imaging, radiation therapy (Council of Medical and Biological Sciences)15 %
Ortelius classification: Radiotherapy
Panel Immunity, Cancer and Microbiology
Department or equivalent National Research Directorate for Radiobiology and Radiohygiene (National Public Health Institute)
Participants Balázsné Persa, Eszter
Bogdándi, Eniko Noémi
Lumniczky, Katalin
Szatmári, Tünde
Starting date 2017-09-01
Closing date 2021-08-31
Funding (in million HUF) 15.964
FTE (full time equivalent) 10.20
state running project




Back »